Cancer Research (BK2573) Stock Price, News, Quotes-Moomoo

Cancer Research Watchlist

Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.

1109.770
+1.221+0.11%

Close Dec 13 16:00 ET

1111.969High1099.271Low

Constituent Stocks: 9Top Rising: PFE+0.83%

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Constituent Stocks

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

PFEPfizer

25.5800.210+0.83%29.04M741.62M25.34025.37025.66025.260144.96B144.75B5.67B5.66B-0.58%-2.40%-1.69%-12.42%-5.88%+1.93%-5.72%6.53%0.51%34.1169.141.58%Drug Manufacturers - General

MRKMerck & Co

102.0000.750+0.74%10.12M1.03B101.130101.250102.570100.530258.02B257.70B2.53B2.53B-1.06%+0.35%+3.70%-12.99%-22.75%-1.10%-4.65%3.02%0.40%21.34728.572.02%Drug Manufacturers - General

BPMCBlueprint Medicines

93.1900.610+0.66%794.13K73.89M92.72092.58093.77092.0005.92B5.86B63.53M62.85M-2.90%-3.31%-2.57%+2.47%-12.54%+5.98%+1.03%--1.26%LossLoss1.91%Biotechnology

GILDGilead Sciences

91.8550.245+0.27%7.52M687.40M91.66091.61092.11089.150114.48B114.25B1.25B1.24B+0.54%+0.05%+0.56%+10.40%+34.31%+19.02%+18.02%3.33%0.60%1020.6120.413.23%Drug Manufacturers - General

ARAYAccuray

1.9200.0000.00%555.19K1.06M1.9201.9201.9421.870193.08M186.40M100.57M97.08M-4.48%-13.90%+10.34%+1.05%+16.36%-28.09%-32.16%--0.57%LossLoss3.75%Medical Devices

NVSNovartis AG

98.360-0.230-0.23%1.23M121.28M98.53098.59098.55097.870196.65B187.66B2.00B1.91B-3.56%-7.01%-4.87%-15.19%-8.39%+4.80%+1.10%3.80%0.07%11.5413.850.69%Drug Manufacturers - General

BMYBristol-Myers Squibb

55.780-0.500-0.89%9.41M523.48M56.38056.28056.38055.040113.13B112.92B2.03B2.02B-6.06%-5.81%-4.65%+15.07%+35.73%+15.15%+14.21%4.30%0.47%Loss14.452.38%Drug Manufacturers - General

EXASExact Sciences

61.250-1.260-2.02%1.48M90.94M62.41062.51063.10060.61011.34B11.25B185.08M183.72M-1.94%-1.34%+20.26%-13.53%+48.05%-7.06%-17.21%--0.81%LossLoss3.98%Diagnostics & Research

BIIBBiogen

150.030-5.300-3.41%1.61M243.04M154.570155.330154.570149.93521.86B21.79B145.72M145.23M-4.91%-6.60%-9.01%-25.52%-32.78%-39.54%-42.02%--1.11%13.5718.822.98%Drug Manufacturers - General

News

Comments

Mr Long Term

Yesterday 08:17

Columns These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over.

It's been a banner year for the stock market. However, not every stock has been a winner as some sectors performed better than others. Tech and utilities soared, while others like real estate and healthcare underperformed.
So what are the five worst performers on the Dow Jones Industrial Average list of blue chip stocks? Let's take a look.
1. Boeing (down 36.5%)
Boeing $Boeing (BA.US)$ has had a r...

Deep Sea

Yesterday 07:31

$Pfizer (PFE.US)$
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company's common stock to $0.43 for the first-quarter 2025 dividend, payable March 7, 2025, to holders of the Common Stock of record at the close of business on January 24, 2025. The first-quarter 2025 cash dividend will be the 345th consecutive quarterly dividend paid by Pfizer.
"Our decision to increase our quarterly dividend underscores our strong fi...

Cow Moo-ney

Dec 12 09:38

Slightly hotter PPI

One day after we got an inflation data (CPI) that came in line with expectation, the market received a hotter-than-expected producer price index (PPI) reading for November.
This is probably why the market is retreating a little bit.
That said, I believe the Fed will still proceed with its expected 25 basis point rate cut next week because other inflation data over the past few months are showing that it is trending downwards.
$Vanguard S&P 500 ETF (VOO.US)$ $KraneShares CSI China Internet ETF (KWEB.US)$ $First Republic Bank (FRCB.US)$ $Crude Oil Futures(FEB5) (CLmain.US)$ $Goldman Sachs (GS.US)$ $Citigroup (C.US)$ $ChargePoint (CHPT.US)$ $LivePerson (LPSN.US)$ $Clover Health (CLOV.US)$ $Vanguard Growth ETF (VUG.US)$ $JD.com (JD.US)$ $Baidu (BIDU.US)$ $FuboTV (FUBO.US)$ $Merck & Co (MRK.US)$ $The Trade Desk (TTD.US)$

https://youtu.be/XKCRqd1-5go

From YouTube

Fed's year-end meeting: How it will reveal market trends!

Moomoo Recap US

Dec 11 15:29

Columns Nasdaq Surges Past 20,000 for the First Time, Powered by Tech Giants | Wall Street Today

The $Nasdaq Composite Index (.IXIC.US)$ hit a record intraday and closing high Wednesday, crossing 20,000 points for the first time. The index was up 1.8% at 20,050 in late trading, finishing 1.77% higher. The $S&P 500 Index (.SPX.US)$ closed just below its highest close on record at 6,090.27, while the $Dow Jones Industrial Average (.DJI.US)$ fell 0.2%.
MACRO
In economic news, November’s consumer price index (C...

Weekly Buzz

Asherboy88

Dec 11 08:09

$Novartis AG (NVS.US)$ what is happening ?? keeps going down